PHARMA INFLUENCERS | NEWSLETTERS | WEBINARS

INDUSTRY NEWS


Newsletter

INDUSTRY NEWS! from The Pharmaceutical Marketing Group is a regular email newsletter about the last news of the pharmaceutical industry

Direct to your inbox

Stay up to date with the latest appointments by subscribing to INDUSTRY NEWS! from The Pharmaceutical Marketing Group

View the newsletter archive

Vifor Pharma acquires Priority Review Voucher

ST GALLEN, Switzerland--(BUSINESS WIRE)--Regulatory News: Vifor Pharma today announced that...

Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia

MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX:...

Sensorion Receives Ethics Committee Approval to Include New Military Sites in SENS-401 Phase 2 study

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering...

Neuropore Therapies Receives $500,000 Grant from The ALS Association to Explore ALS Treatments that Inhibit Neuronal Damage from Disease-Related Inflammation

SAN DIEGO--(BUSINESS WIRE)--Neuropore Therapies, Inc., a biopharmaceutical company discovering...

TASI Group Acquires CASSEL Messtechnik GmbH, Increasing Global Packaging Inspection and Integrity Impact

MARLBOROUGH, Mass. & DRANSFIELD, Germany--(BUSINESS WIRE)--TASI Group (www.tasigroup.com) and...

Free Drug Development Deals and Pipeline Tool; Collaboration between PharmaCompass and SCORR Marketing

PharmaCompass, a digital B2B pharmaceutical intelligence platform, and SCORR...

TherapeuticsMD and Afaxys Enter Into Agreement to Expand Access to ANNOVERA® in the U.S. Public Health Sector

BOCA RATON, Fla. & CHARLESTON, S.C.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ:...

Acorda Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today provided...

FORMA Therapeutics Announces Publication of Olutasidenib’s Molecular Design and Potential Utility in the Journal of Medicinal Chemistry

WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics, Inc., a clinical stage biopharmaceutical...

PharmaCyte Biotech Receives Certificates of Analysis and Batch Records for its Clinical Trial Product in Pancreatic Cancer

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (OTCQB: PMCB), a...

Elanco Signs Agreement with Vetoquinol to Divest Rights for Drontal® and Profender® Within the European Economic Area and the United Kingdom

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) announced...

AmorChem Invests in Novel Approach to Target Myc-driven Cancers

MONTREAL--(BUSINESS WIRE)--AmorChem II is proud to announce the financing...